Investigating the use of Keap1-Nrf2 disruptors for neuroprotection in Alzheimer’s disease

Mohamed Elsharkasi, Geoffrey Wells, Fiona Kerrr

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - May 2022

Cite this